ACTG 303--RISK STATUS FOR DISEASE PROGRESSION AND RESPONSE TO ANTIAIDS AGENT

ACTG 303--疾病进展的风险状态和抗艾滋病药物的反应

• 批准号: 6114298
• 负责人: JOHN G BARTLETT
• 金额: $ 2.06万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6114298
• 关键词: AIDS therapy; antiAIDS agent; clinical research; combination chemotherapy; disease /disorder proneness /risk; human subject; human therapy evaluation; longitudinal human study; pathologic process

To further assess patients previously enrolled in ACTG 175 who were assigned to combination therapy.

为了进一步评估之前入组ACTG 175的患者， 分配到联合治疗。